CVE-2019-15931 — Intesync Solismed 3

Intesync Solismed 3.3sp allows Directory Traversal, a different vulnerability than CVE-2019-16246.

01What is this vulnerability?

Intesync Solismed 3.3sp allows Directory Traversal, a different vulnerability than CVE-2019-16246.

02Affected products

Vendor	Product	Versions
n	a / n/a	n/a

03Active exploitation status

Not currently listed on the CISA Known Exploited Vulnerabilities (KEV) catalog. EPSS is the best forward-looking signal — see the EPSS row above.

04Recommended remediation

• Patch to a fixed version listed in the vendor advisory (see references below).
• Mitigate with WAF rules, network egress filters, or feature flags where the patch is not yet available.
• Hunt historical logs for exploitation indicators — see Detection signatures below.

05Technical details

For the full vendor write-up, exploit chains, and reference implementations, see the references list in section 09.

06Detection signatures

Ask SARA in chat to draft a starting detection for this CVE in your stack of choice.

07Related CVEs

08Timeline

• Published: 2019-12-12T13:38:23.000Z
• Last modified: 2024-08-05T01:03:32.586Z

09References

• www.bishopfox.com — https://www.bishopfox.com/blog/news-category/advisories/
• www.solismed.com — https://www.solismed.com/
• bishopfox.com — https://bishopfox.com
• know.bishopfox.com — https://know.bishopfox.com/advisories/solismed-critical